- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03751696
Coaching Intervention in Women At-risk of Common Mental Disorders
April 18, 2021 updated by: Professor Eric Y.H. Chen, The University of Hong Kong
Coaching Intervention to Improve Mental Well-being of Community Women Who Are At-risk of Common Mental Disorders in Hong Kong: A Pilot Randomized Controlled Trials
This study aims to provide preventative intervention to 60 women who are at risk of common mental disorders in Hong Kong.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Participants will be recruited through the following routes: 1) by our partner non-governmental organizations, 2) by our research team through community outreach or training activities, 3) online screening tool, and 4) referral from organizations that provide service to women (e.g., Maternal and Child Health Clinics of Department of Health).
Eligible subjects with informed consent provided will be randomly assigned to coaching group or SMS self-help tips.
To test the effectiveness of the provided intervention programs, symptoms assessments and data collection on demographics and psychosocial data will be carried out during baseline, immediately, and 3 months post-intervention.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Suen YN, PhD
- Phone Number: 22554486
- Email: suenyn@hku.hk
Study Contact Backup
- Name: Chan Yuk Yu
- Phone Number: 22554486
- Email: vinciyy@connect.hku.hk
Study Locations
-
-
-
Hong Kong, Hong Kong, 0000
- Recruiting
- University of Hong Kong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Willing to provide written informed consent
- Able to understand Cantonese and read/write Chinese
- With subsyndromal or minor depressive symptoms indicated by
- Depression subscale of Depression, Anxiety and Stress Scale (DASS) score 10-20 or
- Edinburgh Postnatal Depression Scale (EPDS) scores 10-13
Exclusion Criteria:
- A positive response in items about suicidal thoughts if applicable ("Yes, quite often" and "sometimes" in EPDS) (These participants will be referred to suicidal management)
- Those mental conditions that require other treatment priorities (e.g., suicidal risk, substance abuse, current or past episodes of psychotic disorder, personality disorders)
- Those medical conditions that severely limit participation, comprehension, or adherence to treatment (e.g., epilepsy, dementia, terminal medical illness)
- Those who are receiving structured psychotherapy or counseling
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Group coaching
There will be a total of 4 sessions of group coaching intervention within 8 weeks.
Each session is in a group of 5-6 women and lasts for approximately 1-1.5 hours.
The sessions will be conducted by experienced social workers online.
|
4 sessions of 1-1.5-hour group coaching intervention within 8 weeks
|
|
ACTIVE_COMPARATOR: SMS Self-help tips
The participants in the control group will receive four self-help tips on mental well-being on the same schedule as the group coaching group.
|
4 mental well-being tips through sms within 8 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms
Time Frame: immediate post-intervention
|
Measured by the depression subscale of the Depression, Anxiety and Stress Scale
|
immediate post-intervention
|
|
Anxiety symptoms
Time Frame: immediate post-intervention
|
Measured by the anxiety subscale of the Depression, Anxiety and Stress Scale
|
immediate post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms
Time Frame: 3-month post intervention
|
Measured by the depression subscale of the Depression, Anxiety and Stress Scale (DASS).
The subscale consists of 7 questions, each responses range from 0 (not applicable) to 3 (the most applicable).
The higher score represents more severe depressive symptoms.
|
3-month post intervention
|
|
Anxiety symptoms
Time Frame: 3-month post intervention
|
Measured by the anxiety subscale of the Depression, Anxiety and Stress Scale
|
3-month post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Eric YH Chen, MD, The University of Hong Kong
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 15, 2018
Primary Completion (ANTICIPATED)
September 30, 2021
Study Completion (ANTICIPATED)
December 31, 2021
Study Registration Dates
First Submitted
November 10, 2018
First Submitted That Met QC Criteria
November 21, 2018
First Posted (ACTUAL)
November 23, 2018
Study Record Updates
Last Update Posted (ACTUAL)
April 20, 2021
Last Update Submitted That Met QC Criteria
April 18, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CoachingRCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Common Mental Disorder
-
New Life Psychiatric Rehabilitation AssociationChinese University of Hong Kong; The Hong Kong Jockey Club Charities TrustCompletedAnxiety | Common Mental Disorder | Depression / Major Depressive DisorderHong Kong
-
Central South UniversityCompletedCommon Mental DisorderChina
-
New York State Psychiatric InstituteUniversity of Pennsylvania; Columbia UniversityCompletedCommon Mental Disorders | Severe Mental DisorderMozambique
-
Université du Québec a MontréalCentre hospitalier de l'Université de Montréal (CHUM); Centre intégré de santé... and other collaboratorsCompletedCommon Mental DisorderCanada
-
Amager HospitalCentral Denmark Region; Københavns Kommune; The Danish Agency for Labour Market... and other collaboratorsCompletedPersonality Disorders | Depression | Stress | Anxiety | Common Mental Disorders | Functional Disease PresentDenmark
-
New Life Psychiatric Rehabilitation AssociationChinese University of Hong KongCompletedCommon Mental Disorders (CMD)Hong Kong
-
King's College LondonCompletedAlcohol Use Disorder | Common Mental DisordersUnited Kingdom
-
Karolinska InstitutetSwedish Council for Working Life and Social ResearchCompletedDepression | Anxiety Disorders | Adjustment Disorders | Common Mental DisorderSweden
-
Instituto Ecuatoriano de Enfermedades DigestivasUniversity of Sao Paulo; Universitair Ziekenhuis Brussel; The Methodist Hospital... and other collaboratorsCompletedCommon Bile Duct Neoplasms | Non-Neoplastic Bile Duct DisorderUnited States, Ecuador, Belgium, Brazil
-
Universidad de CórdobaMinisterio de Economía y Competitividad, SpainCompletedDepression | Anxiety Disorders | Somatoform Disorders | Common Mental DisordersSpain
Clinical Trials on Group Coaching
-
Aava MedicalUniversity of Helsinki; Finnish Institute for Health and Welfare; Finnish Institute...UnknownBurnout | Metabolic Syndrome | Lipid Metabolism Disorders | Work Related Stress | Lifestyle Risk ReductionFinland
-
Institut Pasteur de LilleCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedSleep Apnea SyndromeFrance
-
McGill University Health Centre/Research Institute...Quebec Breast Cancer FoundationNot yet recruiting
-
Thomas Jefferson UniversityEnrolling by invitationSpinal Cord Injury | Students | Ehlers Danlos Syndrome | Care GiversUnited States
-
University of Wisconsin, MadisonCompleted
-
Saglik Bilimleri UniversitesiNot yet recruiting
-
Emory UniversityUniversity of Colorado, Denver; Children's Healthcare of AtlantaCompleted
-
Health Resources and Services Administration (HRSA)University of Pennsylvania; University of California, Davis; University of Rochester and other collaboratorsCompleted
-
University of California, Los AngelesCompleted